Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MRK:GR

104.972 EUR 0.862 0.83%

As of 11:35:18 ET on 04/24/2015.

Snapshot for Merck KGaA (MRK)

Open: 103.970 Day's Range: 103.940 - 105.650 Volume: 364,679
Previous Close: 104.110 52wk Range: 59.375 - 112.335 1-Yr Rtn: +80.64%

Stock Chart for MRK

No chart data available.
  • MRK:GR 105.150
  • 1D
  • 1M
  • 1Y
104.110
Interactive MRK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRK

Current P/E Ratio (ttm) 39.7621
Estimated P/E(12/2015) 20.7989
Relative P/E vs. DAX 2.0202
Earnings Per Share (EUR) (ttm) 2.6400
Est. EPS (EUR) (12/2015) 5.0470
Est. PEG Ratio 2.9841
Market Cap (M EUR) 45,639.50
Shares Outstanding (M) 129.24
30 Day Average Volume 505,758
Price/Book (mrq) 3.8870
Price/Sale (ttm) 4.0419
Dividend Indicated Gross Yield 0.95%
Cash Dividend (EUR) 1.0000
Dividend Ex-Date 04/20/2015
5 Year Dividend Growth 14.87%
Next Earnings Announcement 05/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRK

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MRK

Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

Karl-Ludwig KleyChairman-Mgmt Board/CEOStefan OschmannDeputy CEO/Vice Chairman-Exec Board
Marcus KuhnertCFO/Member-Exec BoardKai BeckmannChief Administration Officer
More Company Profile & Key Executives for MRK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil